Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vasopressin and urinary concentration: additional risk factors in the progression of chronic renal failure.

× No keyword cloud information.

4 in total

1. Renal response to an oral protein load in patients with central diabetes insipidus before and after treatment with vasopressin.

Authors: Davide Viggiano; Natale G De Santo; Nagoth Joseph Amruthraj; Giovanna Capolongo; Giovambattista Capasso; Pietro Anastasio
Journal: J Nephrol Date: 2019-02-19 Impact factor: 3.902

2. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.

Authors: Tadashi Okada; Toshifumi Sakaguchi; Ikuji Hatamura; Fumie Saji; Shigeo Negi; Haruhisa Otani; Yasuteru Muragaki; Hiroshi Kawachi; Takashi Shigematsu
Journal: Clin Exp Nephrol Date: 2009-05-19 Impact factor: 2.801

3. Association between smoking and chronic kidney disease: a case control study.

Authors: Rabi Yacoub; Habib Habib; Ayham Lahdo; Radwan Al Ali; Leon Varjabedian; George Atalla; Nader Kassis Akl; Saleem Aldakheel; Saeed Alahdab; Sami Albitar
Journal: BMC Public Health Date: 2010-11-25 Impact factor: 3.295

4. The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure.

Authors: Tomoyuki Otsuka; Yukinao Sakai; Dai Ohno; Tsuneo Murasawa; Naoki Sato; Shuichi Tsuruoka
Journal: Clin Exp Nephrol Date: 2013-03-13 Impact factor: 2.801

4 in total